Hspa4 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The HSPA4 gene encodes Hsp70 family member 4 (also known as APG-2 or Hsp70RY), a member of the Hsp70 family of heat shock proteins. HSPA4 is a molecular chaperone involved in protein folding, refolding, and degradation. It plays important roles in cellular stress response and has been implicated in various neurodegenerative diseases.
| Property |
Value |
| Gene Symbol |
HSPA4 |
| Full Name |
Heat Shock Protein Family A (Hsp70) Member 4 |
| Chromosomal Location |
1q22 |
| NCBI Gene ID |
3309 |
| UniProt ID |
Q9Y4X5 |
| Protein Class |
Hsp70 Family |
HSPA4 (also known as Hsp70L1 or Apg-2) is a constitutively expressed Hsp70 family member with multiple cellular functions:
- Protein Folding: Assists in proper protein folding as a molecular chaperone
- Stress Response: Induced by heat shock and other cellular stresses
- Apoptosis Regulation: Interacts with Bcl-2 family proteins to regulate apoptosis
- Protein Quality Control: Targets misfolded proteins for degradation via proteasome or autophagy
- Signal Transduction: Modulates various signaling pathways including NF-κB and MAPK
- Hsp70 family members are upregulated in AD brain
- May help clear Aβ aggregates
- Therapeutic target for enhancing protein clearance
- May protect against α-synuclein toxicity
- Hsp70/Hsp40 combinations shown to reduce inclusions
- Gene therapy approaches using Hsp70 being explored
- Altered Hsp70 expression in ALS models
- Mutant SOD1 interacts with Hsp70 pathway
- Potential therapeutic target
- HSPA4 overexpression in various cancers
- Associated with poor prognosis
- Anti-cancer drug target
Hsp70 family members are attractive drug targets:
- Hsp70 inhibitors: 2-phenylethynesulfonamide (PES) and derivatives
- Hsp70 inducers: Geranylgeranylacetone (GGA) approved in Japan
- Combination therapy: Hsp70 + Hsp40 for protein aggregation diseases
- Gene therapy: AAV-delivered Hsp70 for neurodegenerative disease
The study of Hspa4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
HSPA4 (Heat Shock Protein Family A (Hsp70) Member 4), also known as APG-2, is a member of the Hsp70 family with chaperone activity:
- Protein binding: Binds to unfolded proteins to prevent aggregation
- ATPase activity: Regulated by J-domain proteins
- Cellular localization: Predominantly cytosolic, with nuclear localization
- Expression: Inducible by stress, constitutively expressed in some tissues
HSPA4 functions in:
- Protein folding: Assists in refolding of stress-damaged proteins
- Protein degradation: Targets misfolded proteins for proteasomal or lysosomal degradation
- Anti-apoptosis: Interacts with apoptosis signaling pathways
- Alzheimer's disease: Modulates Aβ toxicity and tau pathology
- Parkinson's disease: Affects α-synuclein aggregation
- Ischemia: Protective against cerebral ischemia
- Therapeutic potential: HSPA4 as a neuroprotective target